Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 28 of the 29 references it cites were found in a registry or an index.

Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference?

Open access
Takeshima, Nozomi, Sozu, Takashi, Tajika, Aran, Ogawa, Yusuke, Hayasaka, Yu, Furukawa, Toshiaki A · 2014 · BMC Medical Research Methodology

Abstract

BACKGROUND: To examine empirically whether the mean difference (MD) or the standardised mean difference (SMD) is more generalizable and statistically powerful in meta-analyses of continuous outcomes when the same unit is used. METHODS: From all the Cochrane Database (March 2013), we identified systematic reviews that combined 3 or more randomised controlled trials (RCT) using the same continuous outcome. Generalizability was assessed using the I-squared (I2) and the percentage agreement. The percentage agreement was calculated by comparing the MD or SMD of each RCT with the corresponding MD or SMD from the meta-analysis of all the other RCTs. The statistical power was estimated using Z-scores. Meta-analyses were conducted using both random-effects and fixed-effect models. RESULTS: 1068 meta-analyses were included. The I2 index was significantly smaller for the SMD than for the MD (P < 0.0001, sign test). For continuous outcomes, the current Cochrane reviews pooled some extremely heterogeneous results. When all these or less heterogeneous subsets of the reviews were examined, the SMD always showed a greater percentage agreement than the MD. When the I2 index was less than 30%, the percentage agreement was 55.3% for MD and 59.8% for SMD in the random-effects model and 53.0% and 59.8%, respectively, in the fixed effect model (both P < 0.0001, sign test). Although the Z-scores were larger for MD than for SMD, there were no differences in the percentage of statistical significance between MD and SMD in either model. CONCLUSIONS: The SMD was more generalizable than the MD. The MD had a greater statistical power than the SMD but did not result in material differences.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1471-2288-14-30

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flowchart for selection of meta-analysis.
Figure 1 Flowchart for selection of meta-analysis.CC BY · PubMed Central
Figure 2 Histogram of I 2 index for MD and SMD.
Figure 2 Histogram of I 2 index for MD and SMD.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

See all 387

Metadata

Authors
Takeshima, N., Sozu, T., Tajika, A., Ogawa, Y., Hayasaka, Y., & Furukawa, T. A.
Affiliations
Kyoto University (JP)
Corresponding author
Takeshima, Nozomi
Venue
BMC Medical Research Methodology
Published
2014-02-21
Volume
14
Issue
1
Pages
30-30
ISSN
1471-2288 (ISSN-L)
OpenAlex
W2127130842
Cited by
387
References
29
Citations by year
2026: 37 · 2025: 39 · 2024: 64 · 2023: 54 · 2022: 46 · 2021: 61 · 2020: 29 · 2019: 17 · 2018: 13 · 2017: 12 · 2016: 12 · 2015: 2 · 2014: 1
FWCI
8.82
Type
journal article
Language
en
Open access
Locations
  • BMC Medical Research Methodology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by)
Topics
  • Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
  • Social Sciences › Sociology and Political Science › Delphi Technique in Research
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Keywords
mean difference, standardized mean difference, effect size reporting, continuous outcomes, generalizability, statistical power, heterogeneity, random effects models, fixed effects model, randomized controlled trials
MeSH terms
Data Interpretation, Statistical, Humans, Random Allocation, Randomized Controlled Trials as Topic, Outcome Assessment, Health Care

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? https://app.cochat.ai/papers/10.1186/1471-2288-14-30
The paper
Takeshima, N., Sozu, T., Tajika, A., Ogawa, Y., Hayasaka, Y., & Furukawa, T. A. (2014). Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Medical Research Methodology. https://doi.org/10.1186/1471-2288-14-30

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.